Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-ORC-10000946 |
Date of registration:
|
2010-07-15 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Inhalation induction of sevoflurane in children with parents
|
Scientific title:
|
Inhalation induction of sevoflurane in children with parents |
Date of first enrolment:
|
2010-08-01 |
Target sample size:
|
control group:150;study group:150; |
Recruitment status: |
Completed |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=8592 |
Study type:
|
Interventional study |
Study design:
|
Randomized parallel controlled trial
|
Phase:
|
Other
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Qingping Wu
|
Address:
|
No. 1277, Jiefang Road, Jianghan District, Wuhan, Hubei, China
430022
|
Telephone:
|
+86 13971605283 |
Email:
|
wu_qingping1968@yahoo.com.cn |
Affiliation:
|
|
|
Name:
|
Qingping Wu
|
Address:
|
No. 1277, Jiefang Road, Jianghan District, Wuhan, Hubei, China
430022
|
Telephone:
|
+86 13971605283 |
Email:
|
wu_qingping1968@yahoo.com.cn |
Affiliation:
|
Department of Anaesthesiology, Union Hospital, Wuhan, Hubei, China |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. ASA1-2, good general condition, Hct>0.35, Plt>100g/l with normal function,normal coagulation;
2. With no serious functional organs (heart, liver, lung and kidney) diseases;
3. With no infectious fever or bacteremia;
4. With no hematopoietic system diseases;
5. Voluntary or refuse to coordinate
Exclusion criteria: 1. Hct <0.35, Plt <50g / l or abnormal function;
2. Coagulopathy;
3. Abnormal platelet depletion disease (eg, splenomegaly);
4. Severe functional organs (heart, liver, lung and kidney) disease;
5. With infection and fever or bacteremia;
6. With hematopoietic system diseases;
7. Not voluntary or refuse to coordinate.
Age minimum:
1
Age maximum:
12
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
children undergoing general anesthesia
|
Intervention(s)
|
control group:inhalation induction of sevoflurane in children with parents;study group:inhalation induction of sevoflurane in children without parents;
|
Primary Outcome(s)
|
modified Yale preoperative anxiety scale;Induction Compliance Checklist;the cost of inhalation induction;modified Yale preoperative anxiety scale;
|
Secondary Outcome(s)
|
the time of inhalation induction;
|
Source(s) of Monetary Support
|
Specific finance department of Ministry of Health, China.
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|